Project Jumpstart, discussed in this article, is an effort by major pharmaceutical manufacturers to test item-level RFID tagging of drugs as an anti-counterfeiting/theft strategy.
In considering the surveillance issues, drugs are certainly a sensitive issue; on the other hand, it would be easy to “shed” the tags, as an end consumer. My question would be more toward the claims for anti-counterfeiting. Given that the means of detecting counterfeits won’t be through detecting a counterfeit tag–tags are easily copied–but in assessing the object’s claimed pedigree, it just seems too complex to work all that well. Any number of insiders could probably compromise such schemes fairly easily, for example; until and unless RFID reading throughout supply chains becomes highly pervasive, a great many products will sport pretty sparse pedigrees as it is.